Dallas, Texas, June 25, 2019 (GLOBE NEWSWIRE) -- Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.
The Depressive Disorder market will undergo a period of steady growth from 2015 to 2025, mainly attributed to the growth in atypical antipsychotics and the expected launch of five pipeline.
Request a sample@https://www.orbisresearch.com/contacts/request-sample/3151055
In 2018, the global Depressive Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Depressive Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Depressive Disorder development in United States, Europe and China.
The key players covered in this study
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly
Glaxosmithkline
H. Lundbeck
Merck
Pfizer
Teva Pharmaceutical
Takeda Pharmaceutical
Access the full research report@https://www.orbisresearch.com/reports/index/global-depressive-disorder-market-size-status-and-forecast-2019-2025
Market segment by Type, the product can be split into
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist And Reuptake Inhibitors
Others
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Long Term Care Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Depressive Disorder status, future forecast, growth opportunity, key market and key players.
To present the Depressive Disorder development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Depressive Disorder are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Buy the research study@https://www.orbisresearch.com/contact/purchase-single-user/3151055
Major points from Table of Contents:
Chapter One: Report Overview
Chapter Two: Global Growth Trends
Chapter Three: Market Share by Key Players
Chapter Four: Breakdown Data by Type and Application
Chapter Five: United States
Chapter Six: Europe
Chapter Seven: China
Chapter Eight: Japan
Chapter Nine: Southeast Asia
Chapter Ten: India
Chapter Eleven: Central & South America
Chapter Twelve: International Players Profiles
Chapter Thirteen: Market Forecast 2019-2025
Chapter Fourteen: Analyst's Viewpoints/Conclusions
Chapter Fifteen: Appendix
Browse more related reports:
Global Major Depressive Disorder (MDD) Market Size, Status and Forecast 2019-2025:
The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives. Browse the full report @ https://www.orbisresearch.com/reports/index/global-major-depressive-disorder-mdd-market-size-status-and-forecast-2019-2025
Major Depressive Disorder Drug Market Insights 2019, Global and Chinese Analysis and Forecast To 2024: The report then estimates 2019-2024 market development trends of Major Depressive Disorder Drug industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. Browse the full report @ https://www.orbisresearch.com/reports/index/major-depressive-disorder-drug-market-insights-2019-global-and-chinese-analysis-and-forecast-to-2024
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +91 895 659 5155
Email ID: enquiry@orbisresearch.com
Follow Us on Linkedin: https://www.linkedin.com/company/orbisresearch